Are you Dr. Demeter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box Med
Rochester, NY 14642Phone+1 585-275-5871Fax+1 585-273-1055
Summary
- Dr. Lisa Demeter, MD is an infectious disease specialist in Rochester, New York. She is currently licensed to practice medicine in New York.
Education & Training
University of RochesterFellowship, Infectious Disease, 1988 - 1993- University of RochesterResidency, Internal Medicine, 1984 - 1988
University of Rochester School of Medicine and DentistryClass of 1984
Certifications & Licensure
NY State Medical License 1988 - 2018
Clinical Trials
Publications & Presentations
PubMed
- 52 citationsPrevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.Amneris E. Luque, Musaret Jabeen, Susan Messing, Christopher Lane, Lisa M. Demeter
The Journal of Infectious Diseases. 2006-08-15 - 131 citationsA Phase 1 Study of a Recombinant Viruslike Particle Vaccine against Human Papillomavirus Type 11 in Healthy Adult VolunteersThomas G. Evans, William Bonnez, Robert C. Rose, Scott Koenig, Lisa M. Demeter
The Journal of Infectious Diseases. 2001-05-15 - 2049 citationsA Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or...Scott M. Hammer, Kathleen Squires, Michael Hughes, Janet M. Grimes, Lisa M. Demeter
The New England Journal of Medicine. 1997-09-11
Grant Support
- Virology/Immunology CoreNational Institute Of Allergy And Infectious Diseases2008–2012
- Impact Of Nnrti-Resistance On Rnase H &Hiv ReplicationNational Institute Of Allergy And Infectious Diseases2007–2008
- Clinical Significance Of HIV Replication FitnessNational Institute Of Allergy And Infectious Diseases2006–2008
- ACTG A5146: Impact Of Therapeutic Drug Monitoring In Salvage RegimensNational Center For Research Resources2005
- ACTG 317: Trial Of Quadruple Drug Induction Treatment In PT W/ Acute HIV InfectNational Center For Research Resources2005
- Donation Of ONE Unit Of BloodNational Center For Research Resources2004–2005
- Impact Of Nnrti Resistance On Rnase H &Hiv ReplicationNational Institute Of Allergy And Infectious Diseases2002–2005
- Impact Of Nnrti Resistance On Rnase H &Hiv ReplicationNational Institute Of Allergy And Infectious Diseases2001
- Dlv Resistance Mutations In HIV ReplicationsNational Institute Of Allergy And Infectious Diseases1998–2000
